FDA Inspection 780775 — David E. Geller
The FDA completed an inspection of David E. Geller on April 30, 2012 in Orlando, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- April 30, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Orlando, FL (United States)
Additional Details
Clinical Investigator (CI)